About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

SUSMED,Inc.(4263) Summary

4263
TSE Growth
SUSMED,Inc.
490
JPY
+38
(+8.41%)
Apr 10, 10:28 am JST
3.33
USD
Apr 9, 9:28 pm EDT
Result
PTS
outside of trading hours
486
Apr 10, 10:16 am JST
Summary Chart Historical News Financial Result
PER
PBR
1.91
Yield
ー%
Margin Trading Ratio
4.38
Stock Price
Apr 10, 2025
Opening Apr 10, 9:19 am
510 JPY 3.46 USD
Previous Close Apr 9
452 JPY 3.10 USD
High Apr 10, 9:19 am
510 JPY 3.46 USD
Low Apr 10, 10:15 am
488 JPY 3.32 USD
Volume
33,600
Trading Value
0.02B JPY 0.11M USD
VWAP
500.83 JPY 3.41 USD
Minimum Trading Value
49,000 JPY 333 USD
Market Cap
8.24B JPY 0.06B USD
Number of Trades
40
Liquidity & Number of Trades
As of Apr 10, 2025
Liquidity
Mid
1-Year Average
266
1-Year High Sep 3, 2024
4,059
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 85,600 1,024,600 11.97
Mar 28, 2025 87,400 1,158,300 13.25
Mar 21, 2025 86,200 1,132,800 13.14
Mar 14, 2025 89,300 1,139,700 12.76
Mar 7, 2025 89,100 1,166,700 13.09
Company Profile
SUSMED, Inc. develops therapeutic applications for patients and provides systems to streamline pharmaceutical development. The company collaborates with pharmaceutical firms.
Sector
Information & Communication
SUSMED, Inc. focuses on developing therapeutic applications and providing support systems for pharmaceutical development. Their insomnia treatment application has received medical device approval and is preparing for insurance coverage. The company is currently developing multiple therapeutic applications, including an exercise therapy app for breast cancer patients and an ACP provision app. SUSMED, Inc. has developed and offers a general-purpose clinical trial system to improve the efficiency of clinical trials, as well as an AI platform called "Awesome Intelligence" for medical data analysis. The company is also working on implementing a remote clinical trial system utilizing blockchain technology. Additionally, SUSMED, Inc. provides DTx development support services for pharmaceutical companies and research institutions.